PA Supreme Court Upholds $70 Million Risperdal Verdict
The Pennsylvania Supreme Court has denied Johnson & Johnson’s request to overturn the $70 million Risperdal verdict upheld by a Superior court panel of judges last year. The case, A.Y. v. Janssen Pharmaceuticals, will now be remanded back to the PA Court of Common Pleas for a second trial to reconsider punitive damages. “We are […]
$8 Billion Verdict: Jury decides J&J should pay in Risperdal case
October 9, 2019: Late yesterday a Philadelphia jury rendered an $8 billion punitive damages verdict against pharmaceutical company Johnson & Johnson for illegally marketing the antipsychotic drug Risperdal, putting young boys at risk for developing female-sized breast tissue. The condition, gynecomastia, is irreversible. “The conduct the jury saw in the courtroom was clear and convincing that J&J disregarded the […]
Judge Urges Appeals Court to Uphold $70M Risperdal Verdict
Philadelphia Court of Common Pleas Judge Paula Patrick urges the Pennsylvania Superior Court to uphold the $70 Million jury verdict in A.Y. v. Janssen Pharmaceuticals. AY is one of many boys who developed gynecomastia after taking Janssen’s anti-psychotic medication Risperdal. This is the 5th trial for Risperdal, with over 6,000 awaiting trial in a consolidated […]
